Mouse Anti-EDA Recombinant Antibody (CBFYM-1081) (V2LY-0425-LY1372)

Yang, R., Mei, Y., Jiang, Y., Li, H., Zhao, R., Sima, J., & Yao, Y. (2022). Ectodysplasin A (EDA) Signaling: From Skin Appendage to Multiple Diseases. International Journal of Molecular Sciences, 23(16), 8911.

Capuzzello, G., Jacinto, J. G. P., Häfliger, I. M., Chapman, G. E., Martin, S. S., Viora, L., ... & Drögemüller, C. (2022). A large deletion encompassing exon 2 of the ectodysplasin A (EDA) gene in a British blue crossbred calf with hypohidrotic ectodermal dysplasia. Acta Veterinaria Scandinavica, 64(1), 1-8.

Wagner, M., Bračun, S., Duenser, A., Sturmbauer, C., Gessl, W., & Ahi, E. P. (2022). Expression variations in ectodysplasin-A gene (eda) may contribute to morphological divergence of scales in haplochromine cichlids. Bmc ecology and evolution, 22(1), 1-16.

Marrero, E., Attal, N., Nimeri, A., McGee, R. M., Benbow, J. H., Thompson, K. J., ... & McKillop, I. H. (2022). Ectodysplasin-A mRNA in exosomes released from activated hepatic stellate cells stimulates macrophage response. Experimental Cell Research, 113297.

Ahmed, H. A., El-Kamah, G. Y., Rabie, E., Mostafa, M. I., Abouzaid, M. R., Hassib, N. F., ... & Sayed, I. S. (2021). Gene Mutations of the Three Ectodysplasin Pathway Key Players (EDA, EDAR, and EDARADD) Account for More than 60% of Egyptian Ectodermal Dysplasia: A Report of Seven Novel Mutations. Genes, 12(9), 1389.

Bayliss, J., Ooi, G. J., De Nardo, W., Shah, Y. J. H., Montgomery, M. K., McLean, C., ... & Watt, M. J. (2021). Ectodysplasin a is increased in non-alcoholic fatty liver disease, but is not associated with type 2 diabetes. Frontiers in Endocrinology, 12, 642432.

Körber, I., Klein, O. D., Morhart, P., Faschingbauer, F., Grange, D. K., Clarke, A., ... & Schneider, H. (2020). Safety and immunogenicity of Fc‐EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects. British journal of clinical pharmacology, 86(10), 2063-2069.

Yang, J., Zhou, W., Zhu, J., Wu, Y., Xu, L., Wang, Y., ... & Yang, Y. (2019). Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease. Clinica chimica acta, 499, 134-141.

Kuony, A., Ikkala, K., Kalha, S., Magalhães, A. C., Pirttiniemi, A., & Michon, F. (2019). Ectodysplasin-A signaling is a key integrator in the lacrimal gland–cornea feedback loop. Development, 146(14), dev176693.

He, F., Wang, H., Zhang, X., Gao, Q., Guo, F., & Chen, C. (2018). Conservation analysis and pathogenicity prediction of mutant genes of ectodysplasin a. BMC Medical Genetics, 19(1), 1-7.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols